in

For advanced, HER2-amplified bile duct cancers, antibody treatment trial shows promising results

For advanced, HER2-amplified bile duct cancers, antibody treatment trial shows promising results

Memorial Sloan Kettering gastrointestinal oncologist Dr. James Harding. Credit: Memorial Sloan Kettering Cancer Center

Bile duct cancers are uncommon and aggressive types of gastrointestinal cancer. They include cholangiocarcinomas, which can form inside or outside of the liver, as well as cancers of the gallbladder, and are highly likely to…


Posted by Editor

NK Store to Open Flagship in Iguatemi in São Paulo, Brazil

NK Store to Open Flagship in Iguatemi in São Paulo, Brazil

That nagging pain: Here’s how you can manage and reduce back pain